Circulating Biomarkers for Immunotherapy Resistance in Liver Cancer

What is the Purpose of this Study?

If you choose to join this study, you will:
- Provide samples of blood, stool, and tumor tissue
- Have your progress tracked by the study team.

You may also be asked to undergo a tumor biopsy.
What is the Condition Being Studied?
Hepatocellular Carcinoma (Liver Cancer)

Who Can Participate in this Study?

Adults with hepatocellular carcinoma (liver cancer) who will begin treatment with an immune checkpoint inhibitor.

Age Group
Adults
Participating Institutions

What is Involved?

We are doing this study to track changes in the make-up of your tumor that occur during your treatment.

Study Details

Full Title
Identification of Circulating Biomarker Candidates for Immunotherapy Resistance in hepatocellular Carcinoma (Biobank HCC)
Principal Investigator

Protocol Number
IRB:
PRO00108320

NCT:
NA
ClinicalTrials.gov
View on ClinicalTrials.gov